Eriksson, E., Wenthe, J., Irenaeus, S., Loskog, A., & Ullenhag, G. (2016). Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring the teff/treg ratio in patients with pancreatic cancer. BioMed Central.
Chicago Style CitationEriksson, Emma, Jessica Wenthe, Sandra Irenaeus, Angelica Loskog, and Gustav Ullenhag. Gemcitabine Reduces MDSCs, Tregs and TGFβ-1 While Restoring the Teff/treg Ratio in Patients With Pancreatic Cancer. BioMed Central, 2016.
MLA CitationEriksson, Emma, et al. Gemcitabine Reduces MDSCs, Tregs and TGFβ-1 While Restoring the Teff/treg Ratio in Patients With Pancreatic Cancer. BioMed Central, 2016.
Warning: These citations may not always be 100% accurate.